Telix Pharmaceuticals And 2 Other Australian Insider Owned Growth Stocks

Global regulators are tightening rules for banks and tech platforms to curb misconduct and improve transparency. That push for cleaner markets puts a spotlight on Australian companies where insiders already have meaningful skin in the game and analysts see strong growth potential. This article walks through three fast growing Australian stocks with high insider ownership, so you can see which businesses management is backing with their own capital.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders and analysts are aligned on the outlook. However, if you want the standouts, these 27 high growth high conviction stocks are the most outstanding.

Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals fits this fast growing, high insider ownership theme because its late-stage radiopharmaceutical programs in prostate and other cancers aim squarely at large, globally relevant treatment and imaging markets. Management is committing serious capital and effort to build these into a much bigger business.

Telix generates most of its roughly US$892 million in segment revenue from Precision Medicine at about US$705 million, with Manufacturing Solutions contributing about US$277 million and inter segment eliminations trimming the total. The stock carries a market value near A$5.2b.

"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S., Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S. expands."

The real swing factor is how one unresolved pressure on future profitability plays out if management continues to pursue that global growth plan.

That unresolved pressure is exactly what the full narrative for Telix Pharmaceuticals unpacks, showing how Telix Pharmaceuticals could see that profitability squeeze ease or accelerate as the global rollout matures.

Codan (ASX:CDA)

Codan sits neatly in this fast growing, insider-backed theme because its metal detection arm gives direct exposure to gold prospecting demand, while a sizeable communications division and global reach help round out the growth story.

Codan designs and sells communications gear and metal detectors worldwide, with about A$506 million from Communications and A$362 million from Metal Detection, plus smaller unallocated revenue, and the stock valued around A$11.3b.

For investors tracking Codan, the appeal is that metal detection gives pure exposure to fast moving gold and prospector demand, while communications contracts tied to defense and public safety add a second engine of growth that can keep earnings moving even when cycles shift.

"Intensifying geopolitical tensions and trends toward de-globalization may disrupt Codan's access to key international markets, especially for its defense and mining communications products, thereby constraining revenue growth and geographic diversification."

What happens to that growth profile if a single assumption about future demand in one core end market stops holding true?

If that assumption cracks or accelerates, the full narrative for Codan shows how Codan's gold exposure and communications pipeline could still decouple, or rapidly compound, from here.

Southern Cross Electrical Engineering (ASX:SXE)

Southern Cross Electrical Engineering plugs into the fast growing decarbonization theme through its work on solar and wind farms, yet most activity still comes from broader electrical, security and communications contracts that generated about A$718.7 million in revenue in Australia, with the stock valued near A$1.5b.

For this screen, Southern Cross Electrical Engineering matters because it links large scale renewable power projects with everyday electrical and data infrastructure, giving you exposure to both decarbonization spend and the build out of critical systems across Australia.

"The company sits downstream of powerful structural drivers, AI workloads, cloud migration, enterprise digitalisation, and data sovereignty requirements, all of which are driving sustained demand for data centre capacity."

One key issue for the story is how a pressure on earnings quality and margins resolves as that data centre and renewables pipeline converts to cash.

As that margin story plays out, the full narrative for Southern Cross Electrical Engineering shows whether Southern Cross Electrical Engineering's data centre tailwinds are quietly masking risk or setting up accelerating earnings power.

Seeking Fresh Alternatives Before They Fly

Fresh ideas move first. Once momentum builds, the best opportunities can get caught and crowded fast. Scan under the radar for now, while it matters, and get in early.

• Spot robust balance sheets before momentum chasers catch on by scanning the curated list of solid balance sheet and fundamentals (12 results) that highlight resilience when conditions get tougher.
• Ride structural shifts in global infrastructure by tracking carefully filtered 43 power grid technology and infrastructure stocks that could benefit as electricity demand and grid upgrades build pace.
• Target cash generating AI leaders instead of story stocks by focusing on hand picked 39 profitable AI stocks that aren't just burning cash that pair real earnings with sector momentum.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com